The publisher would like to draw the readers’ attention to errors in the following article:
How we use recombinant activated Factor VII in patients with haemophilia A or B complicated by inhibitors. Intern Med J 2012; 42: 1243–1250., , , , , , , , .
Page 1245, first column, first sentence at the beginning of the last paragraph: The sentence currently reads “Prophylactic treatment in patients with haemophilia A or B helps to significantly bleeding reduce episode frequency. …”. It should read as “Prophylactic treatment in patients with haemophilia A or B helps to significantly reduce bleeding episode frequency, …”
Page 1248: In Reference 8, the symbol is incorrect and should be ®
ie.Ref 8. Novo Nordisk Australasia. NovoSeven®.RT Australian Approved Product Information. 18 August 2008.
The publisher apologises for the errors in the article and for any confusion caused.